COMBINATIONS OF A 5-HT1B ANTAGONIST WITH A NORADRENALIN RE-UPTAKE INHIBITOR OR A SEROTONIN NORADRENALIN REUTAKE INHIBITOR FOR TREATING CNS CONDITIONS

摘要

The present invention relates to pharmaceutical compositions comprising 5-HTSUB1B/SUB antagonists in combination with noradrenaline re-uptake inhibitor (NRI) or serotonin noradrenaline reuptake inhibitor (SNRI) and optionally a pharmaceutically acceptable carrier, and to their medicinal use in treating or preventing CNS conditions such as depression, anxiety, cognitions, ADHD, and comorbid indications.